Regulatory News
Thursday, December 15, 2016
UPDATE 2-Merck wins $2.54 bln in hepatitis C drug trial against Gilead
Dec 15 (Reuters) - Merck & Co on Thursday was
awarded $2.54 billion in royalties by a federal jury in a patent
lawsuit against Gilead Sciences Inc over Gilead's
blockbuster hepatitis C drugs Sovaldi...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment